Chronic malnutrition (prevention)

logo enov'mum

 

 

 

 

Lipid-based Nutrient Supplement Small Quantity (LNS-SQ) 

20 g individual sachet

✓ Nutritional support to pregnant and lactating women
✓ Improves the development of the foetus and the infant

For pregnant and lactating women

 1 sachet / day / woman


→ This product fits home fortification programs, from conception to the end of breastfeeding

 

Quotation request

Enov'Mum™+ is a Lipid-based Nutrient Supplement Small Quantity (LNS-SQ)


 
✓ For pregnant and lactating women

Enov’Mum™+ has been developed in collaboration with researchers from the iLiNS Project operating in Ghana, Malawi, and Burkina Faso to prevent deficiencies of pregnant and lactating women whose diet may provide energy but lacks varied and nutritious food, and to promote adequate growth of their fetus. 

Enov’Mum™+ can be distributed as part of a nutrition program through blanket feeding in at-risk area alongside other interventions, such as Behavior Change Communication (BCC) activities to improve nutritional practices, as well as obstetric care.

 

✓ To fortify diet during pregnancy & exclusive breastfeeding

Growing evidence points out that supplementation during pregnancy and lactation can improve maternal micronutrient status and birth outcomes. That is why it is crucial to manage the nutritional status of mothers-to-be as early as possible. Enov’Mum™+ contains essential fatty acids (EFA) and the recommended daily nutrient intake (RNI) in multiple micronutrients that are often lacking in the diet. The objective is to have a positive effect on maternal nutritional status on pregnant women and children at birth and for its future growth.

All nutritional studies highlight the first 1000 days of life, from conception to two years, as crucial for the development of a child.

Enov Booklet

Enov’Mum™+ is not a substitute for a varied nutritious diet. 

Immediate breastfeeding after birth, exclusive during the first 6 months and recommended for at least 24 months.

 

Studies

Key evidences of acceptability:

  • Ghana:

Well accepted by mothers[1]

 

Key evidences of efficacy:

  • Bangladesh:

Improved birth outcomes in newborn of women supplemented with SQ-LNS during pregnancy compared to IFA in Bangladesh: increased birth weight, birth length, head circumference[2]; stronger effect in severe food insecurity context.

  • Ghana:

Increased birth weight in women supplemented with SQ-LNS during pregnancy[3] compared to IFA-supplemented women in Ghana; stronger effect in primiparous and younger women (in which the rate of low birth weight and low birth length was higher).

Lower prevalence of inadequate gestational weight gain in SQ-LNS group (57,4%) compared to MMN (67,2%)[4] in Ghana.

 

[1] Adu-Afarwuah et al. « Acceptability of lipid-based nutrient supplements (LNS) among Ghanaian infants and pregnant and lactating women » (2011) Maternal and Child Nutrition - https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1740-8709.2010.00286.x

[2] Mridha et al. « Lipid-based supplements for pregnant women reduces newborn stunting in a cluster-randomized controlled effectiveness trial in Bangladesh” (2016) The American Journal of Nutrition. - https://academic.oup.com/ajcn/article/103/1/236/4662854

[3] Adu-Afarwuah et al. « Lipid-based nutrient supplement increases the birth size of infants of primiparous women in Ghana” (2015) The American Journal of Nutrition. - https://europepmc.org/abstract/med/25833980

[4] Adu-Afarwuah et al. « Maternal Supplementation with SQ-LNS compared with MMN, but not with IFA, reduces the prevalence of low gestational weight gain in semi-urban Ghana: a RCT” (2016) The journal of Nutrition - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368579/